AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
18min chapter
Episode 125: AML Series, Pt 11 - Treatment of patients unfit for intensive therapy
The Fellow on Call: The Heme/Onc Podcast
Advancements in AML Treatment for Fragile Patients
This chapter evaluates the progress in treating acute myeloid leukemia (AML) for patients unfit for intensive therapies, focusing on the use of azacitidine and venetoclax. The discussion highlights significant clinical trials, including Viali-A and LACEWING, demonstrating improved response rates and survival outcomes while addressing the challenges of myelosuppression management. Additionally, the speakers emphasize the importance of trial data in informing treatment strategies and the implications of cost-effectiveness in clinical practice.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode